Adaptive Design

  • Process and Regulatory Changes Making Rare Cancer Drug Development More Efficient
  • Ethical Considerations in Adaptive Design Clinical Trials
  • Analgesia

  • Design Considerations for Single-Dose Analgesia Trials in Acute Pain
  • Developing Analgesia Studies:
  • Designed Especially For Kids
  • A Delayed Onset Muscle Soreness (DOMS) Model for the Evaluation of Topical Analgesics
  • Dermatology

  • Psoriasis: An Introduction
  • The Changing Landscape of Psoriasis Treatment
  • Emerging Therapies for Atopic Dermatitis
  • What’s New in Acne
  • Hematology/Oncology

  • Rapid Change, Real Promise: The Future of Rare Oncology Research
  • Maximizing Success in Early Stage Oncology Trials
  • Process and Regulatory Changes Making Rare Cancer Drug Development More Efficient
  • Immuno-Oncology Drug Development: Opportunities Beyond Hope
  • Five Things To Know When it Comes to iRECIST
  • Medical Device and Diagnostics

  • Applying Sound Research Practices in the Development of Medical Devices
  • Clinical Endpoint Committees: Ensuring the Quality, Validity, and Integrity of Clinical Trial Results
  • Medical Device Development: Pathways to Approval in the U.S. and the EU
  • Medical Writing

  • Preparing an IND: Common Errors and Solutions
  • Neuroscience

  • Measuring How Well Subjects Know and Do in CNS Trials
  • Strategies for Collecting Quality Data in Psychiatric Clinical Trials
  • Neurodegenerative Disease Research: Steps to a Successful Clinical Trial
  • Pediatrics

  • Involving Children, Adolescents, and Parents in Pediatric Drug Development
  • The Science and Art of Conducting Clinical Trial Feasibility in Rare Disease and Pediatric Studies
  • Designed Especially For Kids
  • Rare Disease

  • Applying Quality by Design to the Rare Disease Population
  • Clinical Trials in Rare Diseases: Every Patient Counts
  • Orphan Drug and Rare Disease Development:
  • Proven Strategies for Rare Disease and Orphan Drug Development in the U.S.
  • The Science and Art of Conducting Clinical Trial Feasibility in Rare Disease and Pediatric Studies
  • The Science of Hope
  • Fit-For-Purpose: A Strategic Approach to Biomarker Method Validation for Rare Disease
  • Process and Regulatory Changes Making Rare Cancer Drug Development More Efficient
  • Registry and Natural History Studies: Vital, Contrasting Roles in Clinical Research
  • Regulatory

  • Navigating Expedited Regulatory Pathways in the U.S. and Europe
  • Orphan Drug and Rare Disease Development:
  • Services

  • Preparing an IND: Common Errors and Solutions